Similar results were observed in prostate cancer, where downregulation of UGDH promotes androgen-independent tumor cell growth by increasing available levels of intracellular androgen [51], which is why it could be considered as a detection marker for this type of cancer [27]. The gene discussed is UGDH; the disease is cancer.